Afonso CL, Tulman ER, Delhon G, et al. (2006) Genome of crocodilepox virus. Journal of Virology 80: 4978–4991.
Alzhanova D, Edwards DM, Hammarlund E, et al. (2009) Cowpox virus inhibits the transporter associated with antigen processing to evade T cell recognition. Cell Host & Microbe 6: 433–445.
Alzhanova D and Fruh K (2010) Modulation of the host immune response by cowpox virus. Microbes and Infection/Institut Pasteur 12: 900–909.
Babiuk S, Bowden TR, Boyle DB, Wallace DB, and Kitching, R.P. (2008). Capripoxviruses: an emerging worldwide threat to sheep, goats and cattle. Transboundary and Emerging Diseases 55, 263–272.
Baughman B, Zhang S, Jin L, et al. (2011) Diagnosis of Deerpox virus infection in a white‐tailed deer (Odocoileus virginianus) fawn. Journal of Veterinary Diagnostic Investigation Official Publication of the American Association of Veterinary Laboratory Diagnosticians, Inc 23: 965–970.
Bergman N, Moraes KC, Anderson JR, et al. (2007) Lsm proteins bind and stabilize RNAs containing 5' poly(A) tracts. Nature Structural & Molecular Biology 14: 824–831.
Berhanu A, King DS, Mosier S, et al. (2009) ST‐246 inhibits in vivo poxvirus dissemination, virus shedding, and systemic disease manifestation. Antimicrobial Agents and Chemotherapy 53: 4999–5009.
Brady G and Bowie AG (2014) Innate immune activation of NFkappaB and its antagonism by poxviruses. Cytokine & Growth Factor Reviews 25: 611–620.
Byun M, Verweij MC, Pickup DJ, et al. (2009) Two mechanistically distinct immune evasion proteins of cowpox virus combine to avoid antiviral CD8 T cells. Cell Host & Microbe 6: 422–432.
Chantrey J, Meyer H, Baxby D, et al. (1999) Cowpox: reservoir hosts and geographic range. Epidemiology and Infection 122: 455–460.
Chen X, Anstey AV and Bugert JJ (2013) Molluscum contagiosum virus infection. The Lancet Infectious Diseases 13: 877–888.
Cudmore S, Cossart P, Griffiths G and Way M (1995) Actin‐based motility of vaccinia virus. Nature 378: 636–638.
Damon I, Murphy PM and Moss B (1998) Broad spectrum chemokine antagonistic activity of a human poxvirus chemokine homolog. Proceedings of the National Academy of Sciences of the United States of America 95: 6403–6407.
Damon IK (2013) Poxviruses. In: Knipe D and Howley PM, (eds). Fields Virology, pp. 2160–2184. Philadelphia: Lippincott Williams and Wilkins.
Doceul V, Hollinshead M, van der Linden L and Smith GL (2010) Repulsion of superinfecting virions: a mechanism for rapid virus spread. Science 327: 873–876.
Downie AW and Espana C (1972) Comparison of Tanapox virus and Yaba‐like viruses causing epidemic disease in monkeys. The Journal of Hygiene 70: 23–32.
Duraffour S, Meyer H, Andrei G and Snoeck R (2011) Camelpox virus. Antiviral Research 92: 167–186.
Esteban DJ and Buller RM (2005) Ectromelia virus: the causative agent of mousepox. The Journal of General Virology 86: 2645–2659.
Fenner F, Henderson DA, Arita I, Jezek Z and Ladnyi ID (1988a) The clinical features of smallpox. In: Smallpox and Its Eradication, pp. 1–68. Geneva: World Health Organization.
Fenner F, Henderson DA, Arita I, Jezek Z and Ladnyi ID (1988b) The intensified smallpox eradication programme, 1967–1980. In: Smallpox and Its Eradication, pp. 421–538. Geneva: World Health Organization.
Gubser C, Hue S, Kellam P and Smith GL (2004) Poxvirus genomes: a phylogenetic analysis. The Journal of General Virology 85: 105–117.
Hammarlund E, Dasgupta A, Pinilla C, et al. (2008) Monkeypox virus evades antiviral CD4+ and CD8+ T cell responses by suppressing cognate T cell activation. Proceedings of the National Academy of Sciences of the United States of America 105: 14567–14572.
Huchzermeyer FW, Huchzermeyer KD and Putterill JF (1991) Observations on a field outbreak of pox virus infection in young Nile crocodiles (Crocodylus niloticus). Journal of the South African Veterinary Association 62: 27–29.
Jezek Z, Arita I, Szczeniowski M, et al. (1985) Human tanapox in Zaire: clinical and epidemiological observations on cases confirmed by laboratory studies. Bulletin of the World Health Organization 63: 1027–1035.
Jin L, McKay A, Green R, Xu L and Bildfell R (2013) Serosurvey for antibody to deerpox virus in five cervid species in Oregon, USA. Journal of Wildlife Diseases 49: 186–189.
Johnston JB, Barrett JW, Nazarian SH, et al. (2005) A poxvirus‐encoded pyrin domain protein interacts with ASC‐1 to inhibit host inflammatory and apoptotic responses to infection. Immunity 23: 587–598.
Kerr PJ (2012) Myxomatosis in Australia and Europe: a model for emerging infectious diseases. Antiviral Research 93: 387–415.
Laliberte JP and Moss B (2014) A novel mode of poxvirus superinfection exclusion that prevents fusion of the lipid bilayers of viral and cellular membranes. Journal of Virology 88: 9751–9768.
Li P, Wang N, Zhou D, et al. (2005) Disruption of MHC class II‐restricted antigen presentation by vaccinia virus. Journal of Immunology 175: 6481–6488.
Medaglia ML, Pereira Ade C, Freitas TR and Damaso CR (2011) Swinepox virus outbreak, Brazil, 2011. Emerging Infectious Diseases 17: 1976–1978.
Milton DK (2012) What was the primary mode of smallpox transmission? Implications for biodefense. Frontiers in Cellular and Infection Microbiology 2: 150.
Moss B (2013a) Poxviridae. In: Knipe DM and Howley PM, (eds). Fields Virology, pp. 2129–2159. Philadelphia: Lippincott Williams and Wilkins.
Moss B (2013b) Poxvirus DNA replication. Cold Spring Harbor Perspectives in Biology 5: a010199.
Moss B, Carroll MW, Wyatt LS, et al. (1996) Host range restricted, non‐replicating vaccinia virus vectors as vaccine candidates. Advances in Experimental Medicine and Biology 397: 7–13.
Paoletti E (1996) Applications of pox virus vectors to vaccination: an update. Proceedings of the National Academy of Sciences of the United States of America 93: 11349–11353.
Parker S and Buller RM (2013) A review of experimental and natural infections of animals with monkeypox virus between 1958 and 2012. Future Virology 8: 129–157.
Perdiguero B and Esteban M (2009) The interferon system and vaccinia virus evasion mechanisms. Journal of Interferon & Cytokine Research 29: 581–598.
Ray CA, Black RA, Kronheim SR, et al. (1992) Viral inhibition of inflammation: cowpox virus encodes an inhibitor of the interleukin‐1 beta converting enzyme. Cell 69: 597–604.
Roberts KL and Smith GL (2008) Vaccinia virus morphogenesis and dissemination. Trends in Microbiology 16: 472–479.
Shirokikh NE and Spirin AS (2008) Poly(A) leader of eukaryotic mRNA bypasses the dependence of translation on initiation factors. Proceedings of the National Academy of Sciences of the United States of America 105: 10738–10743.
Smee DF (2013) Orthopoxvirus inhibitors that are active in animal models: an update from 2008 to 2012. Future Virology 8: 891–901.
Smith GL, Benfield CT, Maluquer de Motes C, et al. (2013) Vaccinia virus immune evasion: mechanisms, virulence and immunogenicity. The Journal of General Virology 94: 2367–2392.
Taylor JM and Barry M (2006) Near death experiences: poxvirus regulation of apoptotic death. Virology 344: 139–150.
Theze J, Takatsuka J, Li Z, et al. (2013) New insights into the evolution of Entomopoxvirinae from the complete genome sequences of four entomopoxviruses infecting Adoxophyes honmai, Choristoneura biennis, Choristoneura rosaceana, and Mythimna separata. Journal of Virology 87: 7992–8003.
Turner PC and Moyer RW (2008) The vaccinia virus fusion inhibitor proteins SPI‐3 (K2) and HA (A56) expressed by infected cells reduce the entry of superinfecting virus. Virology 380: 226–233.
Upton C, Slack S, Hunter AL, Ehlers A and Roper RL (2003) Poxvirus orthologous clusters: toward defining the minimum essential poxvirus genome. Journal of Virology 77: 7590–7600.
Wagenaar TR and Moss B (2009) Expression of the A56 and K2 proteins is sufficient to inhibit vaccinia virus entry and cell fusion. Journal of Virology 83: 1546–1554.
Weli SC and Tryland M (2011) Avipoxviruses: infection biology and their use as vaccine vectors. Virology Journal 8: 49.
Yang Z, Bruno DP, Martens CA, Porcella SF and Moss B (2011) Genome‐wide analysis of the 5' and 3' ends of vaccinia virus early mRNAs delineates regulatory sequences of annotated and anomalous transcripts. Journal of Virology 85: 5897–5909.
Yang Z, Martens CA, Bruno DP, Porcella SF and Moss B (2012) Pervasive initiation and 3'‐end formation of poxvirus postreplicative RNAs. The Journal of Biological Chemistry 287: 31050–31060.
Barry M, van Buuren N, Burles K, et al. (2010) Poxvirus exploitation of the ubiquitin‐proteasome system. Viruses 2: 2356–2380.
Cottingham MG and Carroll MW (2013) Recombinant MVA vaccines: dispelling the myths. Vaccine 31: 4247–4251.
Essbauer S, Pfeffer M and Meyer H (2010) Zoonotic poxviruses. Veterinary Microbiology 140: 229–236.
Gilbert SC (2013) Clinical development of modified vaccinia virus Ankara vaccines. Vaccine 31: 4241–4246.
Haller SL, Peng C, McFadden G and Rothenburg S (2014) Poxviruses and the evolution of host range and virulence. Infection, genetics and evolution. Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases 21: 15–40.
Kreijtz JH, Gilbert SC and Sutter G (2013) Poxvirus vectors. Vaccine 31: 4217–4219.
Mansur DS, Smith GL and Ferguson BJ (2014) Intracellular sensing of viral DNA by the innate immune system. Microbes and infection/Institut Pasteur 16: 1002–1012.
Schmidt FI, Bleck CK and Mercer J (2012) Poxvirus host cell entry. Current Opinion in Virology 2: 20–27.
Smith GL (2014) Rapid spreading and immune evasion by vaccinia virus. Advances in Experimental Medicine and Biology 808: 65–76.
Welch MD and Way M (2013) Arp2/3‐mediated actin‐based motility: a tail of pathogen abuse. Cell Host & Microbe 14: 242–255.